Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000317529 | SCV000484123 | likely benign | Factor XII deficiency disease | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000372080 | SCV000484124 | likely benign | Hereditary angioneurotic edema | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001528482 | SCV002504214 | likely benign | not provided | 2020-01-08 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Fulgent Genetics, |
RCV002504199 | SCV002811814 | likely benign | Factor XII deficiency disease; Hereditary angioedema type 3 | 2021-07-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001528482 | SCV004158119 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | F12: BS1, BS2 |
Mayo Clinic Laboratories, |
RCV001528482 | SCV004227160 | uncertain significance | not provided | 2022-07-29 | criteria provided, single submitter | clinical testing | BS1, PS3 |
Prevention |
RCV004555573 | SCV004796581 | likely benign | F12-related disorder | 2022-08-03 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV001528482 | SCV001740302 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001528482 | SCV001954206 | likely benign | not provided | no assertion criteria provided | clinical testing |